HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia.
Zhang L, Guo W, Fu YH, Wu D, Li M, Chen YC, Tseng CY, Hua WK, Nguyen LXT, He X, Dong H, Zhang L, Zhang B, Li L, Marcucci G, Kuo YH.
Zhang L, et al.
Leukemia. 2026 Apr 21. doi: 10.1038/s41375-026-02950-1. Online ahead of print.
Leukemia. 2026.
PMID: 42014858